Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer. [electronic resource]
Producer: 20160202ISSN:- 1460-2105
- Aged
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Gene Expression Regulation, Neoplastic
- Gene Fusion
- Gene Rearrangement
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Lamin Type A -- antagonists & inhibitors
- Liver Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptor, trkA -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.